003220 On Other Exchanges
Symbol
Exchange
Korea SE
text size: T | T
Back to Snapshot
Company Description

Contact Info

386 Cheonhodae-ro

Seongdong-gu

Seoul,

South Korea

Phone: 82 2 2204 7000

Fax: 82 2 498 9108

Daewon Pharmaceutical Co., Ltd., a pharmaceutical company, produces and sells medicine and medical supplies in South Korea. The company offers various medicines for circulatory, respiratory, antibiotic, chemotherapy, and psychoneurosis uses. Its principal products include Oramin-F Soft Cap, a multivitamin product; Pelubi Tablet, a NSAID product for pain relief; Freefol-MCT Inj., a microemulsion propofol for the anti-exogenous infectious bacteria; Megex-I Susp, a medicine that supplements subalimentation of cancer patients; Trigel Susp, a therapy for gastritis and duodenal ulcer; and Renamezin Cap, a spherical carbonaceous adsorbent for chronic kidney disease. The company also exports its products to approximately 45 countries primarily in Asia, Central and South America, the Middle East, etc. Daewon Pharmaceutical Co., Ltd. was founded in 1958 and is headquartered in Seoul, South Korea.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

003220 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 003220.
View Industry Companies
 

Industry Analysis

003220

Industry Average

Valuation 003220 Industry Range
Price/Earnings 13.1x
Price/Sales 1.1x
Price/Book 1.7x
Price/Cash Flow 12.7x
TEV/Sales 0.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact DAEWON PHARMACEUTICAL CO LTD, please visit www.daewonpharm.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.